ResearchMetabolic dysfunction-associated steatotic liver disease correlates with higher lower graft survival in liver transplant recipients with hepatocellular carcinoma
ResearchBurden of illness for patients with primary biliary cholangitis: an observational study of clinical characteristics and healthcare resource utilization
ResearchAzathioprine or Mycophenolate Mofetil: Which Should Be Used in Patients With Autoimmune Hepatitis?
ResearchPerformance of the Mayo Risk Score in Predicting Transplant and Mortality in a Single-Center U.S. Cohort of Primary Sclerosing Cholangitis
Apr 14, 2025Journal ArticleA nationwide study of primary biliary cholangitis prevalence, geographic distribution, and health care providers.Written by 1 Roon author & 9 others Via Hepatology Communications
ResearchRecurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival
ResearchSafety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial
ResearchPrimary biliary cholangitis has the worst quality of life indicators among the autoimmune liver diseases: A United States cohort
ResearchPrognostic value of liver stiffness measurement vs. biochemical response in primary biliary cholangitis
ResearchEvolving trends and comparative outcomes of bridging transarterial locoregional therapy in liver transplant candidates with hepatocellular carcinoma
ResearchHepatocellular Carcinoma Recurrence After Liver Transplantation: Current Insights and Future Directions
ResearchOutcomes of Living-Donor Liver Transplantation for Cholangiocarcinoma Versus Hepatocellular Carcinoma in the United States
ResearchImpact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Fatigue and Pruritus in Primary Sclerosing Cholangitis: A U.S. Single-Center Study
ResearchPrimary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?